ATE296352T1 - Werkstoffe und verfahren zur modulierung der p66 expression - Google Patents

Werkstoffe und verfahren zur modulierung der p66 expression

Info

Publication number: ATE296352T1
Authority: AT; Austria
Prior art keywords: shc; serine; expression; vitro; vivo
Prior art date: 1999-03-22

Application number

AT00911131T

Other languages

English (en)

Inventor

Pier Giuseppe Pelicci

Marco Giorgio

Enrica Migliaccio

Luisa Lanfrancone

Original Assignee

Congenia S R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-22

Filing date

2000-03-22

Publication date

2005-06-15

2000-03-22 Application filed by Congenia S R L filed Critical Congenia S R L

2005-06-15 Application granted granted Critical

2005-06-15 Publication of ATE296352T1 publication Critical patent/ATE296352T1/de

Links

238000000338 in vitro Methods 0.000 abstract 2
238000001727 in vivo Methods 0.000 abstract 2
230000004792 oxidative damage Effects 0.000 abstract 2
238000006366 phosphorylation reaction Methods 0.000 abstract 2
101150018665 MAPK3 gene Proteins 0.000 abstract 1
241000699670 Mus sp. Species 0.000 abstract 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
238000002679 ablation Methods 0.000 abstract 1
230000002950 deficient Effects 0.000 abstract 1
230000006801 homologous recombination Effects 0.000 abstract 1
238000002744 homologous recombination Methods 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000035772 mutation Effects 0.000 abstract 1
230000001590 oxidative effect Effects 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1
230000003938 response to stress Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT00911131T 1999-03-22 2000-03-22 Werkstoffe und verfahren zur modulierung der p66 expression ATE296352T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9906515.3A GB9906515D0 (en)	1999-03-22	1999-03-22	Materials and methods relating to the effects oF P66 expression
PCT/GB2000/001079 WO2000056886A1 (en)	1999-03-22	2000-03-22	MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION

Publications (1)

Publication Number	Publication Date
ATE296352T1 true ATE296352T1 (de)	2005-06-15

Family

ID=10850083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00911131T ATE296352T1 (de)	1999-03-22	2000-03-22	Werkstoffe und verfahren zur modulierung der p66 expression

Country Status (10)

Country	Link
EP (1)	EP1163335B1 (de)
JP (1)	JP2002539789A (de)
AT (1)	ATE296352T1 (de)
AU (1)	AU778301B2 (de)
CA (1)	CA2367464A1 (de)
DE (1)	DE60020348T2 (de)
DK (1)	DK1163335T3 (de)
ES (1)	ES2243237T3 (de)
GB (1)	GB9906515D0 (de)
WO (1)	WO2000056886A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1654377A4 (de) *	2002-03-01	2010-03-24	Roger Williams Hospital	MIT DEM Shc-PROTEIN VERBUNDENE VERFAHREN UND ZUSAMMENSETZUNGEN ZUR PROGNOSE VON BRUST-, PROSTATA- UND EIERSTOCKKREBS
GB0722759D0 (en) *	2007-11-20	2008-01-02	Congenia S R L	Antisense oligonucleotides for the modulation of gene expression and methods relating to the use thereof
US20140179774A1 (en) *	2012-12-26	2014-06-26	Industrial Technology Research Institute	Methods for inhibition of shc-1/p66 to combat aging-related diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5744313A (en) *	1994-12-09	1998-04-28	The Regents Of The University Of California	Assay employing novel protein domain which binds tyrosine phosphorylated proteins

1999
- 1999-03-22 GB GBGB9906515.3A patent/GB9906515D0/en not_active Ceased
2000
- 2000-03-22 WO PCT/GB2000/001079 patent/WO2000056886A1/en not_active Ceased
- 2000-03-22 AU AU33124/00A patent/AU778301B2/en not_active Ceased
- 2000-03-22 DK DK00911131T patent/DK1163335T3/da active
- 2000-03-22 CA CA002367464A patent/CA2367464A1/en not_active Abandoned
- 2000-03-22 EP EP00911131A patent/EP1163335B1/de not_active Expired - Lifetime
- 2000-03-22 JP JP2000606745A patent/JP2002539789A/ja active Pending
- 2000-03-22 ES ES00911131T patent/ES2243237T3/es not_active Expired - Lifetime
- 2000-03-22 AT AT00911131T patent/ATE296352T1/de not_active IP Right Cessation
- 2000-03-22 DE DE60020348T patent/DE60020348T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2002539789A (ja)	2002-11-26
EP1163335A1 (de)	2001-12-19
GB9906515D0 (en)	1999-05-19
DE60020348T2 (de)	2006-02-02
CA2367464A1 (en)	2000-09-28
DK1163335T3 (da)	2005-09-19
AU778301B2 (en)	2004-11-25
DE60020348D1 (de)	2005-06-30
EP1163335B1 (de)	2005-05-25
ES2243237T3 (es)	2005-12-01
AU3312400A (en)	2000-10-09
WO2000056886A1 (en)	2000-09-28

Similar Documents

Publication	Publication Date	Title
ATE229007T1 (de)	2002-12-15	6-benzyl-2h-pyridazin-3-on derivate,deren herstellung und deren verwendung als inhibitoren der prostaglandin g/h synthase i and ii (cox i and cox ii)
WO2004045592A3 (en)	2004-11-04	Compounds and methods for increasing neurogenesis
SV1999000102A (es)	2000-07-06	Compuestos heterociclicos como inhibidores de enzimas de rotamasa. ref. pcs 9475 afae/bb.
DE69840519D1 (de)	2009-03-19	Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor
AU2203701A (en)	2001-07-09	Apparatus for and method of making electrical measurements on objects
YU97902A (sh)	2006-05-25	Ciklopentanoindoli, smeše koje sadrže takva jedinjenja i metodi lečenja
WO2001064214A3 (en)	2002-05-10	Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
EP1580268A4 (de)	2006-07-19	D-aminotransferasemutante und verfahren zur herstellung eines optisch aktiven glutaminsäurederivats unter verwendung davon
TR200101307T2 (tr)	2002-05-21	Antranilik asit amidler ve ilaç olarak kullanılmaları.
BG103977A (en)	2000-11-30	Low molecular rotamase enzymic activity inhibitors
TR199901905T2 (xx)	1999-10-21	2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
BG101132A (en)	1998-04-30	Pyridoanilated thienyl and furanyl oxazolidinons
NO306779B1 (no)	1999-12-20	Naftalamider, anvendelse derav og farmasöytisk preparat
ES2191076T3 (es)	2003-09-01	Nuevos derivados de 1-aril-pirazol y su empleo como plaguicidas.
DE69839939D1 (de)	2008-10-09	Tropoelastinderivate
ES2191070T3 (es)	2003-09-01	Arilalquil-piridazinonas.
AU3146400A (en)	2000-09-04	Source of current with series connected cells
ATE330963T1 (de)	2006-07-15	Amorphe feste modifikation von bis(2,4- dicumylphenyl) pentaerythritdiphosphit
ITMI20020960A1 (it)	2003-11-07	Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale
WO2000030667A3 (en)	2000-12-28	Compositions and methods using lactadherin or variants thereof
ATE296352T1 (de)	2005-06-15	Werkstoffe und verfahren zur modulierung der p66 expression
PT983272E (pt)	2004-03-31	Nova classe de compostos fotoactivos derivados de benzoporfirina
CA2227711A1 (en)	1998-07-22	Thioctic acid metabolites and methods of use thereof
ATE408009T1 (de)	2008-09-15	Identifizierung und charakterisierung einer anthocyaninmutante (ant1) in tomate
DE69922936D1 (de)	2005-02-03	Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten

Legal Events

Date

Code

Title

Description

2006-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1163335

Country of ref document: EP

2008-01-15

EEIH

Change in the person of patent owner

2010-12-15

REN

Ceased due to non-payment of the annual fee